Vital Therapies Stock Price (NASDAQ:VTL)

Add to My Stocks
$2.8 $0.15 (5.66%) VTL stock closing price Jul 20, 2017 (Closing)
Prev Close* : $2.65
Market Cap:
$109.74M
Day Low: $2.6
52 Week Low: $2.25
Open: $2.6
Volume: 105297
Day High: $2.85
52 Week High: $6.68
Dividend:
N/A

Latest Stock Market News

Latest Articles

Vital Therapies News - From Partners

VTL Stockcharts

View VTL PE ratio, PS ratio stocks charts and compare with peers.
VTL Chart
Note: Compare Vital Therapies stock price history with the index and industry peers.

VTL Industry Peers

Company Price Change (%)
Pluristem Therapeutics (PSTI)1.180 (0%)
Hedgepath Pharma (HPPI)0.330.01 (3.13%)
Cumberland Pharma (CPIX)6.880.03 (0.43%)
Chembio Diagnostics (CEMI)6.050 (0%)
Corgenix Medical (CONX)0.260.01 (3.7%)
Akers Biosciences (AKER)1.150 (0%)
Erba Diagnostics (ERBA)0.230.03 (11.54%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)40.936.85 (20.1%)
Vericel Corp (VCEL)3.350.2 (6.35%)
Novavax (NVAX)1.510.09 (6.34%)
Uniquire (QURE)8.280.48 (6.15%)
Vital Therapies (VTL)2.80.15 (5.66%)
BioDelivery Sciences (BDSI)3.150.15 (5%)
Idera Pharma (IDRA)1.90.08 (4.4%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 20, 2017
CompanyPriceChange (%)
Inovio Pharma (INO)6.010.77 (11.36%)
AVEO Pharmaceuticals (AVEO)2.520.11 (4.18%)
Epizyme (EPZM)13.30.4 (2.92%)
Immunomedics (IMMU)8.620.25 (2.82%)
Paratek Pharma (PRTK)220.55 (2.44%)
Geron (GERN)2.810.07 (2.43%)
Organovo (ONVO)2.320.05 (2.11%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 20, 2017

Vital Therapies Inc Stock News - Partner Headlines

Vital Therapies Financial Statements

income statement20162015201420132012
Net Sales Or Revenues-----
Net Income-40.96M-52.02M-47.66M-32.71M-6.7M
Total Operating Expense41.26M52.11M50.33M31.39M9.57M
view Vital Therapies Inc income statement
balance sheet20162015201420132012
Total Assets64.02M89.08M108.08M46.58M-
Total Liabilities5.58M6.75M10.51M7.76M-
Shareholders Equity58.44M82.32M97.56M38.81M-
view Vital Therapies Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-1.37M-3.28M5.82M1.03M-
Net Cash From (Used By) Operating Activities-35.77M-49.95M-40.82M-28.64M-
Increase (Decrease) In Prop Plant And Equipment-0.55M-2.34M-1.4M-1.48M-
view Vital Therapies Inc cashflow statement

Vital Therapies Stock Message Board

An investor needs to spend 2.65 to buy VTL stock, as the closing Vital Therapies stock price is 2.65. The total market value as denoted by 109.74M for Vital Therapies, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Vital Therapies stock analysis.

The terms stocks and shares mean the same thing. For Ex: Vital Therapies stock price and Vital Therapies share price mean the same thing. 58199 shares were traded with a closing stock price of 2.65 as of 19 Jul, 2017, as can be seen from Vital Therapies stock quote. One can view Vital Therapies stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Vital Therapies stock price history, gives the entire historical data for VTL stock.